Establishment of Patient-Derived LADC Organoids
(A) Overview of experimental design.
(B) Expansion potential of LADC organoids established. Arrow, continuous expansion. Dot, passage.
(C) Representative H&E staining of LADC tissues together with the bright-field images and H&E staining of the organoids derived from corresponding tumor tissues. Early passage (passage 5–10) and late passage (>10). Scale bar, 100 μm.
See also Figure S2, Tables S1 and S2.